 |
Open for inclusion |
A phase Ib/II open label, multicentre study of PDR001 in combination with MCS110 in patients with advanced malignanciesCancer type: Melanoma, Pancreatic cancer, Solide tumores Phase: I/II Principal Investigator: Joensuu Heikki Country: FI Keywords: Finland, Helsinki Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02807844?term=2016-000210-29&rank=1 |